“tetraphase-pharmaceuticals” Archives

Entry Author Date Location
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference 09/15/10 Boston
VC Investment in New England Declines in Second Quarter (Two Out of Three Surveys Say); Top 10 Deals Dominated by Biotech 07/19/10 Boston
Third Rock Invests in Ablexis, Acceleron Grabs $8.4M, Alnylam Chief Joins Agios Board, & More Boston-Area Life Sciences News 06/25/10 Boston
Massachusetts Startups Pull in $186M in May; Life Sciences Companies Take the Top Five Deals 06/24/10 Boston
Follica Grabs $7.5M, Glaxo’s SR One Leads $22M Round For Constellation, MoMelan Seeks to Improve Skin Grafts, & More Boston-Area Life Sciences News 06/04/10 Boston
Zipcar Files for $75M IPO, Tetraphase Gets $45M, Covidien Acquires ev3 for $2.6B, & More Boston-Area Deals News 06/02/10 Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics 06/01/10 Boston
TetraPhase Pharmaceuticals Receives $45,000,000 Series C Financing 06/01/10 Boston
Google Backs Adimab, PVI Sweetens E Ink Deal, Sanofi-Aventis Partners With Merrimack Pharma, & More Boston-Area Deals News 10/02/09 Boston
Genzyme Faces More Setbacks, Humedica Creating a Healthcare “Census,” Pops Back as Alkermes CEO, & More Boston-Area Life Science News 09/30/09 Boston
TetraPhase Pharmaceuticals Secures $10,000,000 New Financing 09/25/09 Boston
Follica’s Fortunes Growing, Icahn’s Biogen Holdings Mounting, Genzyme’s Mipomersen Work Progressing, & More Life Sciences News 08/13/08 Boston
A123 Files For “Lucky” IPO, BP Shells out $90M for Verenium’s Biofuel Tech, Alnylam Ventures into New RNA Realm, & More Deals News 08/11/08 Boston
TetraPhase Aims to Fill the Antibiotic Pipeline—and its Executive Office 10/05/07 Boston
Boston’s New Generation of University Spinoffs 09/06/07 Boston
Boston’s New Generation of University Spinoffs: The List 09/06/07 Boston
Page 2 of 2 « previous page